Comparisons of Differentiation Potential in Human Mesenchymal Stem Cells from Wharton's Jelly, Bone Marrow, and Pancreatic Tissues
Background. Type 1 diabetes mellitus results from autoimmune destruction of β-cells. Insulin-producing cells (IPCs) differentiated from mesenchymal stem cells (MSCs) in human tissues decrease blood glucose levels and improve survival in diabetic rats. We compared the differential ability and the cur...
Saved in:
Main Authors: | Shih-Yi Kao (Author), Jia-Fwu Shyu (Author), Hwai-Shi Wang (Author), Chi-Hung Lin (Author), Cheng-Hsi Su (Author), Tien-Hua Chen (Author), Zen-Chung Weng (Author), Pei-Jiun Tsai (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2015-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative Analysis of Mesenchymal Stem Cells Isolated from Human Bone Marrow and Wharton's Jelly
by: Narges Talebian, et al.
Published: (2013) -
The Immunomodulatory Potential of Wharton's Jelly Mesenchymal Stem/Stromal Cells
by: Fernanda Vieira Paladino, et al.
Published: (2019) -
Interaction between Macrophages and Human Mesenchymal Stromal Cells Derived from Bone Marrow and Wharton's Jelly-A Comparative Study
by: Marta Dymowska, et al.
Published: (2021) -
Evaluating the Differential Effects of Valproic Acid on Wharton's Jelly Mesenchymal Stem Cells
by: Homa Salami, et al.
Published: (2019) -
Effects of Wharton's jelly-derived mesenchymal stem cells on neonatal neutrophils
by: Khan I, et al.
Published: (2014)